Articles
Proposed Bill to Protect Genetic Information
Singapore's Ministry of Health is consulting on a proposed Bill to protect genetic information in insurance and employment decisions; the proposal is not yet legislation and is distinct from the existing insurance moratorium.
Proposed Bill to Protect Genetic Information
The consultation window is now closed. MOH's page was updated on 8 September 2026, but that update does not itself mean that Parliament has received the Bill, that the proposal was enacted, or that any proposed restriction has commenced. The authoritative status remains consultation-stage policy until a Bill is tabled, passed and brought into force (MOH, updated 8 September 2026).
Singapore's Ministry of Health (MOH) is consulting on a proposed Bill to strengthen safeguards for genetic information. The public consultation runs from 7 August 2026, 10am, to 4 September 2026, 6pm, and MOH says the Bill is expected to be tabled in Parliament in 2027 (MOH, 7 August 2026). The proposal is not legislation in force; its eventual wording, commencement and parliamentary outcome remain to be determined.
Why MOH is proposing the Bill
Genetic testing can identify a person's predisposition to particular diseases and may support prevention, earlier screening or treatment. MOH says it is establishing national programmes for tests where there are clear gene–disease relationships and proven interventions. The National Familial Hypercholesterolaemia Genetic Testing Programme launched in June 2025, and MOH plans to subsidise testing and relevant interventions for Hereditary Breast and Ovarian Cancer from December 2026 (MOH, 7 August 2026).
MOH's stated policy concern is that people may avoid useful testing because they fear genetic results could be used outside healthcare, including in insurance underwriting or employment decisions. The proposed protections are therefore presented as a way to give people confidence to make testing decisions based on health considerations. Subsidy arrangements remain limited to selected programmes, and a genetic result can still be clinically relevant to care.
Proposed protections in insurance and employment
The proposed scope is broader than the selected national testing programmes that MOH names as policy context. It is also narrower than a general claim that every use of genetic information in every setting would be prohibited: the consultation described insurance and employment decisions as the initial non-clinical settings. The public material does not settle the final definitions, exceptions, enforcement mechanism or treatment of every possible use, so those details should not be presented as enacted rules (MOH, 7 August 2026).
The consultation describes rules that would prevent insurers and employers from requiring genetic testing, or from requesting or using genetic information in insurance and employment decisions (MOH, 7 August 2026). MOH says the intended protection would extend beyond genetic information generated under national programmes to all genetic information, including information derived from commercially available genetic tests. The consultation describes policy direction, not a final statutory text or a completed list of exceptions, enforcement provisions or commencement dates.
Relationship to the existing insurance moratorium
The proposed Bill would build on the MOH–Life Insurance Association (LIA) Moratorium on Genetic Testing and Insurance, introduced in 2021, which seeks to protect genetic test results from use in insurance underwriting (MOH, 7 August 2026). The moratorium and the proposed Bill are not interchangeable: the former is the current insurance arrangement described by MOH, while the latter is a proposed statutory framework that would address insurance and employment and would cover genetic information more broadly. The consultation page does not say that the moratorium has been repealed, or that its terms already apply to employment decisions; the proposed Bill's protections are not yet applied to employment decisions. Do not describe the consultation as proof that a new Act has already replaced the moratorium.
Consultation status and interpretation
The consultation window is closed, but closure is not enactment. Feedback submitted by 4 September 2026 at 6pm will inform MOH's development of the proposed policies, while MOH says the proposed Bill is expected to be tabled in Parliament in 2027 (MOH, 7 August 2026; REACH, updated 4 September 2026). Until a Bill is enacted and commenced, readers should treat the proposed restrictions as consultation-stage policy, not as a new offence or a current universal prohibition on every use of genetic information.
Feedback submitted during the consultation will inform MOH's development of the proposed policies. The consultation closes on 4 September 2026 at 6pm; MOH's release says the proposed Bill is expected to be tabled in Parliament in 2027 (MOH, 7 August 2026). Until a Bill is enacted and commenced, readers should treat the proposed restrictions as consultation-stage policy, not as a new offence or a current universal prohibition on every use of genetic information. The proposal also should not be confused with the separate clinical programmes that expand access to selected genetic testing and interventions.
Record details
- Also known as
- ["proposed Bill to protect genetic information","Genetic Information Bill","genetic information protection Bill","genetic information legislation"]
- Jurisdiction
- SG
Dates describe this record’s own period and applicability. A verification date does not mean a rule is currently in force.
Sources
- MOH — Public consultation on proposed Bill to protect genetic information Accessed 2026-09-12
- REACH — Public consultation on proposed Bill on protecting genetic information Accessed 2026-08-20
Collection as of 2026-10-07 · An expanding collection. Published counts show available knowledge, not complete coverage of Singapore.